Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7365 p275
3 September 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Web pharmacies put people's lives at risk, think-tank concludes

People's lives are at risk unless the Government does something to prevent prescription medicines being sold via the internet without proper safeguards or controls. This is the conclusion of a seminar hosted by the Centre for Reform think-tank.

Nick Bromley, director of health research at the Centre for Reform, said: “It must be a matter of most urgent concern that people can obtain heroin substitutes over the internet by simply using a search engine, or that they can obtain the more old-fashioned anti-depressants which may have dangerous side effects for some people without any supervision.”

The report argues for a simple, consumer friendly procedure that people can use to check whether the medicines they buy via the internet are coming from legitimate sources.

Simon Williams, director of policy at the Patients’ Association, said: “If people do not have a simple and quick way of being able to check if an online pharmacy is legitimate they will simply not check before ordering and will be putting their health at serious risk. Regulators must address this matter now.”

A report of the seminar says that the Royal Pharmaceutical Society is working on a logo that legitimate UK pharmacy websites could use to indicate that they are properly registered.

“It would be important that patients could also check this easily and quickly via a link to the register,” the report adds. However, it warns that criminals would have no scruples about copying the logo and that it would need wide publicity so that people knew that they should look for it on pharmacy websites.

The seminar also questioned whether Government agencies were putting sufficient effort into closing down rogue websites quickly. “This is an area where constant harassment of the unscrupulous is necessary,” the report says.

Back to Top


©The Pharmaceutical Journal